Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | SHBG | P04278 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | HBB | P68871 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adonitol SCHEMBL19182208 | 0.84 | ALDH1A1 (0.38) | TP53TDP1PYCR1KMT2ARAB9A | |
| SCHEMBL10023965 | 0.82 | S1PR1 (0.40) | TDP1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL233241 | 0.82 | AMY1A (0.43) | TP53TDP1KMT2AALDH1A1MEN1 | |
| SCHEMBL30150898 | 0.82 | AMY1A (0.43) | TP53TDP1KMT2AALDH1A1MEN1 | |
| SCHEMBL10979415 | 0.82 | NPC1 (0.39) | PYCR1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL3678782 | 0.81 | TP53 (0.44) | TP53TDP1PYCR1KMT2ARAB9A | |
| SCHEMBL30585189 | 0.81 | TP53 (0.44) | TP53TDP1PYCR1KMT2ARAB9A | |
| SCHEMBL30585190 | 0.81 | TP53 (0.44) | TP53TDP1PYCR1KMT2ARAB9A | |
| SCHEMBL92914 | 0.80 | TAAR1 (0.56) | TP53TDP1KMT2ARAB9ANPC1 | |
| SCHEMBL6547406 | 0.79 | TAAR1 (0.48) | TP53TDP1PYCR1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1942 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | BASF SE (DE) | 2026-02-24 | — | — | US | claimed |
| EP-3947600-B1 | SOIL CONDITIONING COMPOSITION AND SOIL CONDITIONING METHOD | W A D GLOBAL B V (NL) | 2025-08-20 | — | — | EP | claimed |
| EP-4308249-A1 | CLEANSING COMPOSITION | Li-iL GmbH Arzneimittel, Arneibäder (DE) | 2024-01-24 | — | — | EP | claimed |
| EP-3763202-B1 | CULTURE SUBSTRATE FOR PLANTS | FLORAGARD BETEILIGUNGS GMBH (DE) | 2023-12-27 | — | — | EP | claimed |
| EP-3995538-B1 | SUGAR-CONTAINING BINDER SYSTEM FOR WOOD MATERIAL BOARDS, A METHOD FOR PRODUCING A WOOD MATERIAL BOARD USING THIS SUGAR-CONTAINING BINDER SYSTEM AND WOOD MATERIAL BOARD OBTAINED BY THIS METHOD | SWISS KRONO Tec AG (CH) | 2023-06-07 | — | — | EP | claimed |
| CN-113308916-B | Dyeing method of aramid fiber and dyed aramid fiber | 常熟市宝沣特种纤维有限公司 | 2023-04-25 | — | — | CN | claimed |
| US-20220375696-A1 | GEL ELECTROLYTE PRECURSOR COMPOSITIONS, ELECTROCHROMIC DEVICES INCLUDING GEL ELECTORLYTES, AND MANUFACTURING METHODS THEREOF | HIVISQ TECHNOLOGIES, SOCIEDAD LIMITADA (ES) | 2022-11-24 | — | — | US | claimed |
| WO-2022194928-A1 | CLEANSING COMPOSITION | LI-IL GMBH ARZNEIMITTEL, ARZNEIBÄDER (DE) | 2022-09-22 | — | — | WO | claimed |
| EP-4059575-A1 | CLEANSING COMPOSITION | Li-iL GmbH Arzneimittel, Arneibäder (DE) | 2022-09-21 | — | — | EP | claimed |
| EP-3967468-A1 | PRODUCTION METHOD FOR MODIFIED LIGNOCELLULOSE MATERIALS | Georg-August-Universität Göttingen (DE) | 2022-03-16 | — | — | EP | claimed |
| EP-0133672-B1 | ADHESIVE STICK AND ITS METHOD OF MANUFACTURE | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-05-27 | — | — | EP | claimed |
| US-4652442-A | Process of producing a sustained release preparation containing indomethacin or niomethacin | ARCANA CHEM. PHARM. FABRIK GESELLSCHAFT M.B.H. (AT) | 1987-03-24 | — | — | US | claimed |
| US-4626427-A | Cardamom seed preparation being effective against bad breath | RICHARDSON-VICKS INC. (US) | 1986-12-02 | — | — | US | claimed |
| US-4483873-A | HYDROGINATED LECITHIN | EISAI CO., LTD. (JP) | 1984-11-20 | — | — | US | claimed |
| US-4474596-A | Xylite derivatives, methods for their production as well as compositions containing them having growth regulatory activity for plants | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-10-02 | — | — | US | claimed |
| US-4427010-A | Method and means for cooling injured parts or areas of a human or animal body | MARX GUENTER H (DE) | 1984-01-24 | — | — | US | claimed |
| US-4358462-A | ENZYMATIC SACCHARIFICATION AND FERMENTATION OF UNPOLISHED RICE | OZEKI SAKE BREWING CO., LTD. (JP) | 1982-11-09 | — | — | US | claimed |
| US-4193801-A | DISSOLVING WATER-INSOLUBLE ADDITIVES IN A MELT OF ACID IMIDE OR DERIVATIVE | CIBA-GEIGY AKTIENGESELLSCHAFT (CH) | 1980-03-18 | — | — | US | claimed |
| US-4146399-A | DISSOLVING A TABLET CONTAINING PHOTOGRAPHIC ADDITIVE IN AQUEOUS COLLOID; COATING ON SUPPORT | CIBA-GEIGY AG (CH) | 1979-03-27 | — | — | US | claimed |
| US-4140530-A | DISPERSION OF FINELY DIVIDED ADDITIVE | CIBA-GEIGY AG (CH) | 1979-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | SAAL1, ATXN2L, VCL | TP53 3252/4885TDP1 1430/4885PYCR1 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.